Johnt Potts News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Johnt potts. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Johnt Potts Today - Breaking & Trending Today

Leerink Partners Remains a Hold on Radius Health (RDUS)

Markets
Leerink Partners analyst Geoff Porges maintained a Hold rating on Radius Health (RDUS – Research Report) on April 22. The company’s shares closed last Friday at $20.90.
According to TipRanks.com, Porges is a 3-star analyst with an average return of 5.9% and a 49.5% success rate. Porges covers the Healthcare sector, focusing on stocks such as Alexion Pharmaceuticals, Vertex Pharmaceuticals, and Theravance Biopharma.
Radius Health has an analyst consensus of Moderate Buy, with a price target consensus of $29.00.
Radius Health’s market cap is currently $980.1M and has a P/E ratio of -8.50. The company has a Price to Book ratio of -7.25. ....

Michael Rosenblatt , Stavrosc Manolagas , Theravance Biopharma , John Katzenellenbogen , Geoff Porges , Johnt Potts , Vertex Pharmaceuticals , Alexion Pharmaceuticals , Radius Health , Research Report On , Radius Health Inc , Leerink Partners , Research Report , Moderate Buy , மைக்கேல் ரோசன்ப்ளாட் , ஜியோஃப் போற்கேஸ் , வெர்டெக்ஸ் மருந்துகள் , அலெக்சியன் மருந்துகள் , ஆரம் ஆரோக்கியம் , ஆராய்ச்சி அறிக்கை ஆன் , ஆரம் ஆரோக்கியம் இன்க் , ஆராய்ச்சி அறிக்கை , மிதமான வாங்க ,